Brief: BiomX Reports Topline Results Of Phase 2 Cosmetic Acne Study
Oct 18 (Reuters) - Biomx Inc PHGE.A :
* BIOMX REPORTS TOPLINE RESULTS OF PHASE 2 COSMETIC ACNE
STUDY
* BIOMX INC - 12-WEEK STUDY OF BX001 MEETS SAFETY AND
TOLERABILITY
ENDPOINTS
* BIOMX INC - STATISTICALLY SIGNIFICANT IMPROVEMENT FROM
BASELINE
OBSERVED IN APPEARANCE OF ACNE-PRONE SKIN
* BIOMX INC - NO MEANINGFUL DIFFERENCE DEMONSTRATED RELATIVE
TO
VEHICLE
* BIOMX INC - SUBJECT SATISFACTION QUESTIONNAIRE OUTCOMES
INDICATE
PREFERENCE FOR BX001 OVER VEHICLE ON KEY PARAMETERS
* BIOMX INC - BX001 WAS DEMONSTRATED TO BE SAFE AND
WELL-TOLERATED
Source text for Eikon: ID:nGNX94SbVP
Further company coverage: PHGE.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Tessera Defense and Homeland Security
See all newsBrief: Tessera Subsidiary Zorronet Expands D4P Group Collaboration Into AI-Powered Critical Infrastructure And Homeland Security Markets Across The EU
Brief: Tessera Defense & Homeland Security - Enters $5 Million Revolving Credit Agreement With Mandragola On Oct 5, 2026 - SEC Filing
Brief: Biomx - Announces One-For-Ten Reverse Stock Split Of Common Stock - SEC Filing
Brief: Biomx And Water.Io Agree To Updated Zorronet Acquisition Terms
Brief: BiomX - May Offer And Sell Up To $9.10 Million Of Common Stock Through Wainwright - SEC Filing